We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

81 hedge funds and large institutions have $730M invested in HilleVax in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

17% more funds holding

Funds holding: 69 → 81 (+12)

6% more capital invested

Capital invested by funds: $686M → $730M (+$44.4M)

4% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 23

0.15% more ownership

Funds ownership: 88.18% → 88.33% (+0.15%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
81
Holders Change
+12
Holders Change %
+17.39%
% of All Funds
1.17%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
17
Increased
24
Reduced
23
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$25.7M
2
Millennium Management
Millennium Management
New York
+$10.8M
3
Deutsche Bank
Deutsche Bank
Germany
+$3.18M
4
BM
Bridger Management
New York
+$1.73M
5
State Street
State Street
Massachusetts
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$13.6M
2
DTC
Deep Track Capital
Connecticut
-$5.24M
3
B
Braidwell
Connecticut
-$3.26M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.99M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$163M – – –
TPC
2
Takeda Pharmaceutical Company
Japan
$112M – – –
DM
3
Deerfield Management
New York
$66.6M – – –
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$50.9M +$25.7M +1,607,914 +111%
DTC
5
Deep Track Capital
Connecticut
$42.8M -$5.24M -327,540 -11%
VA
6
VR Adviser
New York
$34.5M – – –
Franklin Resources
7
Franklin Resources
California
$30.8M +$128K +8,000 +0.4%
CG
8
Carlyle Group
District of Columbia
$30.5M – – –
BlackRock
9
BlackRock
New York
$29.9M +$389K +24,340 +1%
Vanguard Group
10
Vanguard Group
Pennsylvania
$22.7M -$1.63M -102,168 -7%
CP
11
Catalys Pacific
Japan
$21.8M – – –
SG
12
StepStone Group
California
$13.7M – – –
SB
13
Samsara BioCapital
California
$13.3M – – –
Millennium Management
14
Millennium Management
New York
$11.3M +$10.8M +676,566 New
Citadel Advisors
15
Citadel Advisors
Florida
$10.8M -$1.2M -75,000 -10%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$10.3M +$491K +30,672 +5%
QUSVM
17
Qiming U.S. Ventures Management
Washington
$9.29M – – –
State Street
18
State Street
Massachusetts
$8.13M +$1.14M +71,488 +17%
Deutsche Bank
19
Deutsche Bank
Germany
$5.14M +$3.18M +198,985 +180%
ACP
20
Acuta Capital Partners
California
$4.17M -$1.18M -73,991 -23%
Northern Trust
21
Northern Trust
Illinois
$4.06M -$59.6K -3,725 -2%
Charles Schwab
22
Charles Schwab
California
$3.43M -$40.1K -2,507 -1%
Walleye Capital
23
Walleye Capital
New York
$2.36M -$1,000K -62,476 -31%
FAM
24
Fred Alger Management
New York
$2.06M -$117K -7,325 -6%
Ensign Peak Advisors
25
Ensign Peak Advisors
Utah
$1.96M – – –
1
2 3 4

HLVX Hedge Fund Activity: Q1 2024 in Review

81 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2024, worth a combined $730M — up 6.5% from $686M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new HLVX positions and 5 closed out — a net gain of 12 holders — while 24 added to existing stakes and 23 trimmed.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $25.7M. The largest seller was Morgan Stanley, cutting an estimated $13.6M.

  • 81 institutional investors held HilleVax (HLVX) as of Q1 2024, up from 69 in Q4 2023.
  • Funds reported $730M of HilleVax stock for Q1 2024, up 6.5% quarter-over-quarter.
  • 17 funds opened new HilleVax positions in Q1 2024 and 5 closed out, a net change of +12 holders.
  • The largest HilleVax buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $25.7M added.
  • The largest HilleVax seller in Q1 2024 was Morgan Stanley, an estimated $13.6M sold.

Based on aggregated 13F filings for Q1 2024.